Harmony Biosciences Holdings, Inc. (HRMY)
41.52
+0.42
(+1.02%)
USD |
NASDAQ |
Sep 11, 16:00
41.52
0.00 (0.00%)
After-Hours: 20:00
Harmony Biosciences Holdings Market Cap : 2.413B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 2.413B |
| September 10, 2026 | 2.389B |
| September 09, 2026 | 2.419B |
| September 08, 2026 | 2.445B |
| September 04, 2026 | 2.456B |
| September 03, 2026 | 2.433B |
| September 02, 2026 | 2.491B |
| September 01, 2026 | 2.397B |
| August 31, 2026 | 2.289B |
| August 28, 2026 | 2.279B |
| August 27, 2026 | 2.317B |
| August 26, 2026 | 2.305B |
| August 25, 2026 | 2.264B |
| August 24, 2026 | 2.238B |
| August 21, 2026 | 2.217B |
| August 20, 2026 | 2.213B |
| August 19, 2026 | 2.321B |
| August 18, 2026 | 2.257B |
| August 17, 2026 | 2.217B |
| August 14, 2026 | 2.216B |
| August 13, 2026 | 2.238B |
| August 12, 2026 | 2.311B |
| August 11, 2026 | 2.297B |
| August 10, 2026 | 2.267B |
| August 07, 2026 | 2.232B |
| Date | Value |
|---|---|
| August 06, 2026 | 2.252B |
| August 05, 2026 | 2.213B |
| August 04, 2026 | 2.244B |
| August 03, 2026 | 2.060B |
| July 31, 2026 | 2.039B |
| July 30, 2026 | 2.075B |
| July 29, 2026 | 2.075B |
| July 28, 2026 | 2.070B |
| July 27, 2026 | 2.084B |
| July 24, 2026 | 2.044B |
| July 23, 2026 | 2.072B |
| July 22, 2026 | 2.017B |
| July 21, 2026 | 2.132B |
| July 20, 2026 | 1.939B |
| July 17, 2026 | 1.954B |
| July 16, 2026 | 1.940B |
| July 15, 2026 | 2.020B |
| July 14, 2026 | 2.014B |
| July 13, 2026 | 2.057B |
| July 10, 2026 | 2.132B |
| July 09, 2026 | 2.211B |
| July 08, 2026 | 2.204B |
| July 07, 2026 | 2.214B |
| July 06, 2026 | 2.142B |
| July 02, 2026 | 2.156B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Liquidia Corp. | 5.947B |
| Repligen Corp. | 9.321B |
| Johnson & Johnson | 639.58B |
| Pfizer Inc. | 157.98B |
| Bristol Myers Squibb Co. | 130.02B |
Market Cap Related Metrics
| PE Ratio | 13.45 |
| PS Ratio | 2.541 |
| Price to Book Value | 2.415 |
| Price to Free Cash Flow | 7.266 |
| Price | 41.52 |
| Earnings Yield | 7.43% |
| Operating PE Ratio | 10.57 |
| Normalized PE Ratio | 13.45 |